Needham & Company analyst Matt Matson initiates coverage on CryoLife (NYSE: CRY) with a Hold rating.The analyst comments "CRY has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE